DEADLINE TOMORROW: Levi & Korsinsky, LLP Notifies Shareholders of Osiris Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2016 - OSIR

NEW YORK, Jan. 21, 2016

To: All persons or entities who purchased or otherwise acquired securities of Osiris Therapeutics, Inc. ("Osiris Therapeutics") (NASDAQ: OSIR) between May 12, 2014 through November 20, 2015.           

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New York. If you purchased or otherwise acquired Osiris Therapeutics between May 12, 2014 and November 20, 2015, your rights may be affected by this action. To get more information go to:

http://zlk.9nl.com/osiris-therapeutics-osir

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Osiris improperly recognized revenue under contracts it had with its distributors; (2) Osiris' disclosure controls and procedures were not effective as of December 31, 2014, March 31, 2015, and June 30, 2015; and (3) as a result, defendants' statements about Osiris' business and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you suffered a loss in Osiris Therapeutics you have until January 22, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.